Asensus Surgical, Inc. announced that Paul LaViolette, who has served as the company’s board chair since 2013, will step down as chair in late October 2021, and intends to leave the board before the end of the year 2021. LaViolette has informed the board of his intention to leave the company’s board due to his other professional commitments. The board intends to appoint David Milne, an existing board member, as the company’s chair after LaViolette steps down. LaViolette will work closely with Milne to ensure a smooth transition of the chair role. Milne has been a board member since 2013. He currently operates a consulting practice, focusing on high growth companies in the medical device and healthcare industries. Previously he was a Managing Partner and led the medical technology practice for 13 years at SV Healthcare Ventures. Before entering venture capital, Milne spent over 20 years as an operating executive in several medical technology companies including Boston Scientific, Becton Dickinson and SCIMED Life Systems. He has had a broad range of leadership positions in business development, marketing, product development and sales. David has been engaged with over 20 private and public company boards over his career including several in which he was a founding board member and/or a Chair of the Board. He currently advises several CEOs in industries focused on medical technology and data science.
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
ASENSUS SURGICAL, INC. 
